2 result(s) displayed (1 - 2 of 2):

Merck, Shire, BIO's Greenwood talk shop in SF (from Corporate Dealmaker)

Nothing like a good industry confab for gathering data points and highlighting trends in a fast-changing sector -- which is what Alex Lash, The Deal's senior writer on the biopharma beat is doing at the Deloitte Recaps Allicense conference in San Francisco on June 16, 17 and 18. He...

Posted on June 18, 2009 10:35 AM

Let there be bio-pharma deals, says trade group chief (from Corporate Dealmaker)

Big Pharmas are cutting costs; Bristol-Myers Squibb Co., Wyeth, Pfizer, Merck & Co., Schering-Plough Corp. and GlaxoSmithKline plc have all announced reductions in their U.S. sales forces. They're also worrying about life under the Democrats.Do they still want to replenish their pipelines with high-priced biotech drugs? James Greenwood, president and...

Posted on November 20, 2008 4:23 PM